Hong Kong stock market anomaly | Vistroke Pharmaceuticals-B (02561.HK) rose more than 15% in early trading. The company recently reached a project collaboration with Meixin Health to explore new payment models.

Chaitin Finance APP learned that Vesheng Pharmaceuticals-B (02561.HK) surged more than 15% in early trading. As of the time of publication, it had risen by 15.22% to 23.02 Hong Kong dollars, with a trading volume of 1.482 million Hong Kong dollars.